3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
14
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Solitary Pulmonary Nodule
1
Rectal Neoplasms
1
Pain, Postoperative
1
Lymphedema
1
Lung Neoplasms
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Adenocarcinoma of Lung
1
Interventions
talimogene laherparepvec
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vorinostat
1
Taxes
1
Radiotherapy, Conformal
1
Paclitaxel
1
Mastectomy, Segmental
1
Mastectomy
1
Carboplatin
1
Brachytherapy
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Ductal, Breast
×
Mastectomy, Segmental
×
90 days
×
Clear all
NCT03909282
2026-03-12
NORDIS
Stanford University
Phase NA
Recruiting
50 enrolled